These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38264503)

  • 41. High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more.
    Suzuki T; Michihata N; Yoshikawa T; Hata T; Matsui H; Fushimi K; Yasunaga H
    Eur J Pediatr; 2020 Dec; 179(12):1901-1907. PubMed ID: 32862279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. School-aged children with Kawasaki disease: high incidence of cervical lymphadenopathy and coronary artery involvement.
    Fan PC; Chiu CH; Yen MH; Huang YC; Li CC; Lin TY
    J Paediatr Child Health; 2003; 39(1):55-7. PubMed ID: 12542814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
    Kibata T; Suzuki Y; Hasegawa S; Matsushige T; Kusuda T; Hoshide M; Takahashi K; Okada S; Wakiguchi H; Moriwake T; Uchida M; Ohbuchi N; Iwai T; Hasegawa M; Ichihara K; Yashiro M; Makino N; Nakamura Y; Ohga S
    Int J Cardiol; 2016 Jul; 214():209-15. PubMed ID: 27070994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and laboratory features and disease outcome of kawasaki disease: the analysis of our experience and literature review.
    Generini S; Ermini M; Taccetti G; Trapani S; Cerinic MM; Falcini F
    J Clin Rheumatol; 1997 Oct; 3(5):241-7. PubMed ID: 19078197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
    Chen CJ; Huang FC; Tiao MM; Huang YH; Lin LY; Yu HR; Yang KD; Huang YC; Chen CC; Chang WC; Kuo HC
    ScientificWorldJournal; 2012; 2012():485758. PubMed ID: 22792043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profile of Kawasaki disease at a tertiary care center in India.
    Bhattad S; Gupta S; Israni N; Mohanty S
    Ann Pediatr Cardiol; 2021; 14(2):187-191. PubMed ID: 34103858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India.
    Jindal AK; Pilania RK; Guleria S; Vignesh P; Suri D; Gupta A; Singhal M; Rawat A; Singh S
    Front Pediatr; 2020; 8():24. PubMed ID: 32117831
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
    Lei WT; Chang LS; Zeng BY; Tu YK; Uehara R; Matsuoka YJ; Su KP; Lee PC; Cavalcante JL; Stubbs B; Lin PY; Wu YC; Hsu CW; Chen TY; Chen YW; Yeh PY; Sun CK; Tseng PT; Kao YH
    EBioMedicine; 2022 Apr; 78():103946. PubMed ID: 35306339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF-α blockers for the treatment of Kawasaki disease in children.
    Yamaji N; da Silva Lopes K; Shoda T; Ishitsuka K; Kobayashi T; Ota E; Mori R
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012448. PubMed ID: 31425625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium-containing versus sodium-trace preparations of IVIG for children with Kawasaki disease in the acute phase.
    Suzuki T; Michihata N; Aso S; Yoshikawa T; Saito K; Matsui H; Fushimi K; Yasunaga H
    Eur J Pediatr; 2021 Nov; 180(11):3279-3286. PubMed ID: 33973071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.
    Chang L; Yang HW; Lin TY; Yang KD
    Front Pediatr; 2021; 9():697632. PubMed ID: 34350146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease.
    Ching LL; Nerurkar VR; Lim E; Shohet RV; Melish ME; Bratincsak A
    Front Pediatr; 2020; 8():295. PubMed ID: 32670996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].
    Liu WQ; Xia B; Fan W; Yu Z; Lin WL; Chen L; Wang C; Liu BN; Li J; Yang J
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):588-593. PubMed ID: 35658368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.